Nutter hosts BPLA’s “Patenting Diagnostics and Natural Products in View of Mayo, Myriad, and USPTO Guidelines”Print PDF
Nutter is hosting the Boston Patent Law Association’s (BPLA) panel meeting and discussion on “Patenting Diagnostics and Natural Products in View of Mayo, Myriad, and USPTO Guidelines” on June 11. Join panelists from the United States Patent and Trademark Office and the Biotechnology Industry Organization as they discuss possible solutions regarding the recent Supreme Court cases and the USPTO guidance.
Raul Tamayo, Legal Advisor, Office of Patent Legal Administration, United States Patent and Trademark Office
Hans Sauer, Deputy General Counsel for Intellectual Property, Biotechnology Industry Organization (BIO)
Donna Meuth, Associate General Counsel, Eisai Pharmaceuticals
Jesper Levin, European Patent Attorney, Jesper Levin, ApS. Topic Patenting Diagnostics and Natural Products in Europe
Moderator: Lin Hymel, McLane Law Firm, Co-Chair Chemical Patent Practice Committee
Wednesday, June 11, 2014
11:30 a.m. – 3:00 p.m.
11:30 a.m. – 12:30 p.m. Registration, Lunch, and Networking
12:30 - 2:00 p.m. Presentations by Panelists
2:00 – 3:00 p.m. Panel Discussion, Q & A
Nutter McClennen & Fish LLP
Louis D. Brandeis Conference Center
Seaport West, 5th Floor
155 Seaport Boulevard, Boston, MA 02210
For more information and to register, click here.